Announced
Completed
Synopsis
IMCD, a global distributor of speciality chemicals and food and pharma ingredients, completed the acquisition of Signet Excipients Private, an Indian speciality chemicals distributor. Financial terms were not disclosed. “As India is the largest supplier of generic medicines globally, it is our ambition for our pharmaceutical business to have a strong presence there. Hence, I am pleased that Signet and IMCD will now join their activities in India, Bangladesh, the Middle East and Africa,” Piet van der Slikke, IMCD CEO. On February 01, 2024, IMCD completed the acquisition of remaining 30% of Signet Excipients.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.